A Phase 3, randomized, double-blind efficacy and safety study comparing SAR442168 to teriflunomide (Aubagio?) in participants with relapsing forms of multiple sclerosis (GEMINI 1)
This Study is
No Longer Enrolling
Details
Age
Adult
Type of Study
Treatment
Locations
Brain Imaging Center (BIC)
University of Colorado Hospital
Study ID
Protocol Number: 20-1101
More information available at ClinicalTrials.gov: NCT04410991
Categories
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers